Facebook Pixel Code

Beryl Drugs Share Price

NSE
BSE

BERYL DRUGS

Sector : Pharmaceuticals and health care | Smallcap | BSE

Here's the live share price of Beryl Drugs along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹24.25
5.43₹ 1.25
As on Sep 24, 2025, 10:45 AM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Beryl Drugs Price Performance

Today's LowToday's High
₹21.56₹24.25
₹24.25
52 Weeks' Low52 Weeks' High
₹17.35₹46.00
₹24.25
Open Price
₹22.99
Prev. Close
₹23.00
Volume
1,652

Over the last 5 years, the share price of Beryl Drugs has gained 30.04% CAGR. Over the past year, the corresponding return has been -33.73%.

Beryl Drugs’s current P/E of 7.50x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.

Beryl Drugs Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Beryl Drugs
01.0528.64-1.37-37.1431.5628.68
Sun Pharmaceutical Industries
0.48-1.73-2.00-8.81-12.8521.9627.38
Divi's Laboratories
-0.27-3.41-8.102.1112.3118.0314.84
Torrent Pharmaceuticals
2.84-0.7214.7011.804.8834.0222.44
Cipla
-2.38-4.931.29-0.14-7.0412.6315.74
Dr. Reddy's Laboratories
-0.731.30-2.697.55-2.1716.345.31
Mankind Pharma
-0.92-0.4910.267.28-6.8221.3512.31
Zydus Lifesciences
0.251.377.5111.96-1.3742.8422.50
Lupin
-1.651.693.47-5.83-9.7945.0715.32
Alkem Laboratories
1.552.6715.6910.04-8.0319.1014.45
Abbott India
-2.42-4.21-4.16-2.826.8619.7613.59
Aurobindo Pharma
0.052.75-0.66-9.33-27.0229.758.09
Glenmark Pharmaceuticals
-1.422.9319.6934.8218.5876.2134.69
Laurus Labs
2.855.2637.3047.4295.5322.8928.90
Biocon
1.02-0.542.612.48-4.609.06-2.60
GlaxoSmithKline Pharmaceuticals
0.40-1.88-14.90-4.731.1425.4512.19
Anthem Biosciences
-5.43-3.1211.8211.8211.823.792.26
Ipca Laboratories
5.12-1.493.33-5.06-7.0215.555.95
Cohance Lifesciences
-8.22-1.23-9.95-24.35-25.1328.4919.17
Gland Pharma
1.463.8514.1725.098.74-0.762.07

Over the last one year, Beryl Drugs has declined 37.14% compared to peers like Sun Pharmaceutical Industries (-12.85%), Divi's Laboratories (12.31%), Torrent Pharmaceuticals (4.88%). From a 5 year perspective, Beryl Drugs has outperformed peers relative to Sun Pharmaceutical Industries (27.38%) and Divi's Laboratories (14.84%).

Beryl Drugs Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Beryl Drugs Stock Technicals

Moving Average

DaySMAEMA
523.523.07
1023.8923.46
2024.3223.45
5022.1122.63
1002122.74
20025.6824.71

Beryl Drugs Share Holding Pattern

In the latest quarter, Beryl Drugs remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding unchanged at 73.61% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Beryl Drugs Corporate Actions

Date Time
Announcement
Sep 04, 2025, 1:09 AM ISTBeryl Drugs Ltd. - Reg. 34 (1) Annual Report.
Sep 02, 2025, 10:20 PM ISTBeryl Drugs Ltd. - NOTICE OF EVOTING FACILITY FOR 32ND ANNUAL GENERAL MEETING 2025
Sep 02, 2025, 10:14 PM ISTBeryl Drugs Ltd. - FIXES RECORD DATE FOR THE PURPOSE OF ANNUAL GENERAL MEETING OF THE COMPANY 23RD SEPTEMBER, 2025
Sep 02, 2025, 10:09 PM ISTBeryl Drugs Ltd. - FIXES BOOK CLOSURE FOR THE PURPOSE OF ANNUAL GENERAL MEETING OF THE COMPANY FROM 24TH SEPTEMBER, 2025 TO 3
Sep 02, 2025, 10:05 PM ISTBeryl Drugs Ltd. - 32ND ANNUAL GENERAL MEETING OF THE COMPANY WILL BE HELD ON 30TH SEPTEMBER, 2025 AT 11:00 AM AT Kanchan Pal

About Beryl Drugs

Beryl Drugs Ltd. is a Public Limited Listed company incorporated on 24/08/1993 and has its registered office in the State of Madhya Pradesh, India. Company's Corporate Identification Number(CIN) is L02423MP1993PLC007840 and registration number is 007840. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 21.15 Cr. and Equity Capital is Rs. 5.09 Cr. for the Year ended 31/03/2025.

Management

  • Mr. Sudhir Sethi
    Chairman & Director
  • Mr. Sanjay Sethi
    Managing Director
  • Mr. Abhinav Naik
    Independent Director
  • Mrs. Shreya Saraf
    Independent Woman Director

FAQs on Beryl Drugs Share Price

What is the share price of Beryl Drugs?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Beryl Drugs is ₹24.25 as on Sep 24, 2025.

What kind of stock is Beryl Drugs?

The Beryl Drugs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Beryl Drugs?

The market cap of Beryl Drugs is ₹11.66 Cr as on Sep 24, 2025.

What are today's High and Low prices of Beryl Drugs?

Today’s highest and lowest price of Beryl Drugs are ₹24.25 and ₹21.56.

What are the 52 Week High and 52 Week Low of Beryl Drugs?

The 52-week high/low is the highest and lowest price at which Beryl Drugs stock has traded in the past 52-week or nearly a year. The 52-week high of Beryl Drugs is ₹46.00 and 52-week low of Beryl Drugs is ₹17.35 as on Sep 24, 2025.

How has the Beryl Drugs performed historically in terms of returns?

The Beryl Drugs has shown returns of 5.43% over the past day, 6.55% for the past month, 35.63% over 3 months, -33.73% over 1 year, 33.9% across 3 years, and 30.04% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Beryl Drugs?

P/E ratio of and PB ratio of Beryl Drugs are 7.50 and 1.92 on Sep 24, 2025. While the company gives a dividend yield of 0.00 per annum.

icon
Market Data